SMD Rise PCL

SMD Rise PCL EV/Revenue

The EV/Revenue (Enterprise Value to Revenue) of SMD Rise PCL (SMD100.BK) as of Oct 19, 2026 is 0.80. In the previous year, EV/Revenue (Enterprise Value to Revenue) was 0.57 — a change of 41.51% (higher).

EV/Revenue

0.80

YoY

41.51%

Last updated:

EV/Revenue (Enterprise Value to Revenue) of SMD Rise PCL is 2025 0.80 . EV/Revenue (Enterprise Value to Revenue) of SMD Rise PCL was 2024 0.57 . It decreases by 41.51% higher compared to the previous year.

The SMD Rise PCL EV/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/Revenue
Date
EV/Revenue
Jan 1, 2018
1.27 THB
Jan 1, 2019
0.90 THB
Jan 1, 2020
1.06 THB
Jan 1, 2021
0.15 THB
Jan 1, 2022
-0.02 THB
Jan 1, 2023
0.19 THB
Jan 1, 2024
0.57 THB
Jan 1, 2025
0.80 THB
The SMD Rise PCL EV/Revenue history
YEAREV/RevenueYoY
0.80+41.51%
0.57+191.91%
0.19-1,010.95%
-0.02-114.63%
0.15-86.28%
1.06+18.48%
0.90-29.69%
1.27-4.50%
1.33+24.84%
1.07—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMD Rise PCL Stock analysis

What does SMD Rise PCL do? SMD Rise PCL, listed on the Stock Exchange of Thailand with ticker SMD100.BK and ISIN THA320A10Y01, operates in the Health Care sector. The company was founded through an IPO on June 17, 2021. SMD Rise PCL is engaged in the distribution of medical devices and equipment, focusing on the import and distribution of medical supplies and services for medical equipment. The company specializes in respiratory system-related medical equipment, particularly offering sleep monitoring services and counseling on the use of positive pressure air compressors (CPAP) for treating obstructive sleep apnea (OSA). Its services target patients with sleep disorders, including snoring, obstructive sleep apnea, insomnia, and other conditions such as excessive daytime sleepiness, sleepwalking, bruxism, and leg twitching. Additionally, the company provides support for patients with high blood pressure, diabetes, and obesity. SMD Rise PCL's subsidiary is Saint Medical Trading Co., Ltd. The company's website is https://www.saintmed.com/. SMD Rise PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMD Rise PCL stock

EV/Revenue (Enterprise Value to Revenue) of SMD Rise PCL is 0.80 in 2025.

EV/Revenue (Enterprise Value to Revenue) of SMD Rise PCL changed from 0.57 to 0.80, representing a 41.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/Revenue (Enterprise Value to Revenue) SMD Rise PCL since 2006 – with annual values, charts, and detailed analysis.

The EV/Revenue ratio compares a company's enterprise value to its total revenue. It is particularly useful for valuing high-growth companies that may not yet be profitable.

To evaluate EV/Revenue (Enterprise Value to Revenue)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/Revenue (Enterprise Value to Revenue).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/Revenue (Enterprise Value to Revenue)'s SMD Rise PCL with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — SMD Rise PCL

All Key Metrics — SMD Rise PCL